Emergex secures funds in race to develop universal flu vaccine
May 15, 2018Manufacturing and Production, Sales and Marketing Emergex, Innovate UK, biotech, drugs, influenza vaccine, pharma, pharmaceutical
UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through preclinical tests, in the hope …
Lilly chalks up another acquisition with AurKa for $575m
May 14, 2018Manufacturing and Production, Sales and Marketing AurKa, Cancer, Eli Lilly, acquisition, oncology, pharma
Swiftly following up its $1.6 billion splash to pick up Armo BioSciences last week, Eli Lilly has agreed to acquire …
Bringing the PRO to fruition
May 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PROs, feature, patient reported outcomes, patient-reported outcomes, pharma
Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …
Medigene and bluebird bio expand immunotherapy partnership to $1.5bn
May 14, 2018Research and Development, Sales and Marketing Bluebird Bio, Cancer, Medigene, pharma
Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …
Takeda financials show why the Shire deal was needed
May 14, 2018Sales and Marketing Shire, Takeda, biotech, drugs, pharma, pharmaceutical
After posting its financials from 2017 and its guidance for the year to come, it’s clear to see why Takeda …
Pharma unfazed by Trump price-reduction proposals
May 14, 2018Medical Communications, Sales and Marketing PhRMA, President trump, biotech, drugs, pharma, pharmaceutical
President Trump’s speech on Friday afternoon had been long-anticipated, ever since he was elected and then hammered the pharma industry …
FDA awards first paediatric MS approval to Novartis’ Gilenya
May 14, 2018Sales and Marketing FDA, gilenya, multiple sclerosis, pharma
The FDA has awarded approval for what it says is its first drug for the treatment of multiple sclerosis (MS) …
Akari CEO resigns over allegations of spending company funds
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, appointment
Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …
Janssen’s Tremfya gets go-ahead from NICE in plaque psoriasis
May 11, 2018Medical Communications, Sales and Marketing Janssen, NICE, Tremfya, UK, pharma, psoriasis
NICE, the UK’s drug watchdog for the NHS, has decided that Janssen’s Tremfya (guselkumab) should be used routinely through the …
Top Ten most popular articles on Pharmafile.com this week
May 11, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, EMA, GSK, J&J, JJ, Novartis, Shire, Takeda, Valeant, biotech, drugs, pharma, pharmaceutical
It’s been a week in which one of the largest pharmaceutical takeovers in history took place and yet it’s not …
Roche’s Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer
May 11, 2018Medical Communications, Research and Development Cancer, Cotellic, Roche, pharma, tecentriq
Roche has been rocked by a Phase 3 weak showing from its combination Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people …
AZ’s Fasenra stumbles in P3 for COPD
May 11, 2018Medical Communications, Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
AstraZeneca’s Fasenra arrived later on the scene than GSK rival med, Nucala, and so it needed to quickly rack up …
DIA – CMC Workshop
May 11, 2018Medical Communications dia
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from …
C4 Therapeutics fills out C-Suite with CEO appointment
May 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing C4 Therapeutics, biotech, drugs, pharma, pharmaceutical
C4 Therapeutics has been slowly expanding since its creation in early 2016 out of the prestigious Dana-Farber Cancer Institute. Andrew …
Lilly moves quickly to secure $1.6bn buyout of Armo
May 10, 2018Medical Communications, Sales and Marketing Armo Biosciences, Eli Lilly, biotech, drugs, pharma, pharmaceutical
Armo BioSciences only went public in January but it has already been snapped up by Eli Lilly for $1.6 billion. …
NanoBots: The science of small to dwarf the disease
May 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma
Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …
FDA launches lawsuits against stem cell clinics after patients rendered blind
May 10, 2018Medical Communications, Sales and Marketing FDA, Stem cells, US, macular degeneration, pharma
At the request of the FDA, The US Department of Justice has launched legal action seeking to shut down stem …
Lodo and Roche go digging for drug candidates, after $1bn deal
May 10, 2018Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
Discovering potential therapeutics from natural sources has been a constant throughout the evolution of medicine, Lodo Therapeutics, however, has taken …
Novartis’ $1.2m payment to Trump’s lawyer raises more questions than answers
May 10, 2018Medical Communications Essential Consultants, Michael Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical
Novartis payment to President Trump’s personal lawyer, Michael Cohen, had seemed fairly odd from the beginning – with many asking …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
